Immunocore Holdings plc announced the appointment of Ralph Torbay as its new Head of Commercial and the appointment of Dr. Roy S. Herbst as a member of its Board of Directors, effective January 28, 2021. Roy Herbst joined the Immunocore Board of Directors in January. He previously served as a member of Immunocore's Scientific Advisory Board (SAB) and is internationally recognized for his leadership and expertise as a physician-scientist in lung cancer treatment and research.